ClinChoice Kunling Funding: $212M Raised, Series E (2022)
ClinChoice Kunling is based in Fort Washington, Pennsylvania. It has raised $212M in total funding. Latest round: Series E.
ClinChoice Kunling funding overview
ClinChoice Kunling is based in Fort Washington, Pennsylvania. ClinChoice Kunling has raised $212M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in July 2022. The round record for ClinChoice Kunling runs through 2022; nothing later has been disclosed. Investors on record include Legend Capital, Taikang Life Insurance, Sherpa Healthcare Partners, Lilly Asia Ventures, Apricot Capital, Goldman Sachs and 1 others. 7 distinct backers are named across the disclosed rounds.
ClinChoice Kunling at a glance
Total raised
$212M
Latest round
Series E
Latest round date
July 2022
Headquarters
Fort Washington, Pennsylvania
Notable investors
Legend Capital, Taikang Life Insurance, Sherpa Healthcare Partners, Lilly Asia Ventures, Apricot Capital, Goldman Sachs, DFJ Dragon Fund
Frequently asked about ClinChoice Kunling funding
How much has ClinChoice Kunling raised?
ClinChoice Kunling has raised $212M in total disclosed funding across the rounds on record.
Who has invested in ClinChoice Kunling?
Legend Capital, Taikang Life Insurance, Sherpa Healthcare Partners, Lilly Asia Ventures, Apricot Capital, Goldman Sachs are named among the investors backing ClinChoice Kunling.
What was the latest ClinChoice Kunling funding round?
The most recent disclosed round is a Series E, announced in July 2022.
Where is ClinChoice Kunling based?
ClinChoice Kunling is based in Fort Washington, Pennsylvania.
When did ClinChoice Kunling last raise?
The last disclosed ClinChoice Kunling round closed in July 2022 at Series E.
Round data for ClinChoice Kunling is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Fort Washington and backer lists below.
